We serve Chemical Name:1-Eth-1-ynyl-4-(pentyloxy)benzene CAS:79887-16-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-Eth-1-ynyl-4-(pentyloxy)benzene
CAS.NO:79887-16-4
Synonyms:1-Eth-1-ynyl-4-(pentyloxy)benzene;1-ethynyl-4-pentyloxybenzene;4-n-Pentylphenylacetylene;4-N-PENTYLOXYPHENYLACETYLENE;1-Ethynyl-4-(pentyloxy)benzene;MFCD00173877;4-Ethynylphenyl pentyl ether;4-n-pentoxyphenylacetylene;Benzene, 1-ethynyl-4-(pentyloxy)-
Molecular Formula:C13H16O
Molecular Weight:188.266
HS Code:2909309090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:271.1±23.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.511
PSA:9.23000
Exact Mass:188.120117
LogP:4.44
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-Eth-1-ynyl-4-(pentyloxy)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzene, 1-ethynyl-4-(pentyloxy)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Ethynylphenyl pentyl ether Use and application,4-Ethynylphenyl pentyl ether technical grade,usp/ep/jp grade.
Related News: The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. 1-Eth-1-ynyl-4-(pentyloxy)benzene manufacturer China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. 1-Eth-1-ynyl-4-(pentyloxy)benzene supplier DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. 1-Eth-1-ynyl-4-(pentyloxy)benzene vendor A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. 1-Eth-1-ynyl-4-(pentyloxy)benzene factory China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.